TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cipla Ltd ( (IN:CIPLA) ) has issued an announcement.
Cipla Limited has announced the allotment of 2,853 equity shares under its Employee Stock Option Scheme 2013-A and the Cipla Employee Stock Appreciation Rights Scheme 2021. This move increases the company’s issued, subscribed, and paid-up share capital to INR 1,61,55,08,148, reflecting its ongoing commitment to employee engagement and retention strategies.
More about Cipla Ltd
Cipla Ltd is a prominent pharmaceutical company based in India, known for its extensive range of medications and healthcare products. It primarily focuses on developing and manufacturing generic drugs and is a key player in the global pharmaceutical industry.
Average Trading Volume: 64,033
Technical Sentiment Signal: Strong Buy
Current Market Cap: 1212.6B INR
See more insights into CIPLA stock on TipRanks’ Stock Analysis page.